share_log

JMP Securities Initiates Coverage On Sana Biotechnology With Market Outperform Rating, Announces Price Target of $9

JMP Securities Initiates Coverage On Sana Biotechnology With Market Outperform Rating, Announces Price Target of $9

JMP Securities以市场跑赢大盘的评级开始报道Sana Biotechnology,宣布目标股价为9美元
Benzinga ·  2023/09/25 05:06

JMP Securities analyst Reni Benjamin initiates coverage on Sana Biotechnology (NASDAQ:SANA) with a Market Outperform rating and announces Price Target of $9.

JMP证券分析师Reni Benjamin对Sana Biotech(纳斯达克:SANA)进行了报道,评级为市场表现优于大盘,并宣布目标价为9美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发